As a member of the Bayer Sustainability Council, it was a privilege to join Dr. Claus Runge, Senior Vice President and Global Head of Public Affairs, Sustainability and Internal Engagement and Chief Health Equity Officer at Bayer Pharmaceuticals, and Dr. Cecilia Caetano, Vice President and Head of Global Medical Affairs for Women’s Health at Bayer, at the Menopause Matters convening hosted by Bayer and Foreign Policy on the sidelines of the WHO 79th World Health Assembly.

By 2030, 1.2 billion women worldwide will be in menopause or postmenopause, many at the peak of their professional and civic lives, and yet menopause remains chronically underfunded, under-researched, and absent from the health systems and workplace policies designed to support them, a reality rigorously documented in the FP Analytics Special Report on the Health and Economic Impacts of Menopause, produced with support from Bayer, and the evidence base that anchored the afternoon’s discussion among policymakers, health practitioners, researchers, and advocates committed to changing that.

As we work collectively to advance Bayer’s global sustainability strategy across health equity, healthcare access, and climate resilience, conversations of this quality and ambition are precisely the mechanism through which practical partnerships are built, actionable solutions are surfaced, and the most systematically neglected issues in global health are finally given the policy attention and investment they demand.

 

View this post on Instagram

 

A post shared by Toyin Saraki (@toyinsaraki)